Stocks and Investing Stocks and Investing
Wed, November 1, 2023
Tue, October 31, 2023

Gil Blum Maintained (SRPT) at Strong Buy with Decreased Target to $82 on, Oct 31st, 2023


Published on 2024-10-28 07:13:43 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Decreased Target from $185 to $82 on, Oct 31st, 2023.

Gil has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Gil's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gil


  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Tuesday, September 26th, 2023
Contributing Sources